Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Smoking and immunomodulators do not influence the response or duration of response to infliximab in Crohn's disease.

Smoking and immunomodulators do not influence the response or duration of response to infliximab in Crohn's disease. Inflamm Bowel Dis. 2004 Jul; 10(4):346-51.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.